Risk Correlation Analysis between Polycystic Ovary Syndrome (PCOS) and Serum Visfatin Levels in Middle-Aged Women: Systematic Review and Meta-Analysis
Authors:
- Yingchun LingYLYingchun Ling
- Xiao YuXYXiao Yu
- Mengna ShouMSMengna Shou
Open Access
- 1 January 2023
- journal article
- review article
- Published by Discovery Medicine in Discovery Medicine
- Vol. 35 (175) , 168-177
Abstract
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder that occurs frequently in women of childbearing age and is associated with insulin resistance. Serum visfatin can affect insulin resistance by binding to insulin receptors and further affect the occurrence and development of PCOS. In this study, we investigated the current status of serum visfatin levels in patients with PCOS through a literature search and meta-analysis. Methods: We searched online Pubmed, Embase, Web of Science, the Cochrane Library, CNKI (China National Knowledge Infrastructure), CBMdisc (China Biology Medicine disc) databases and registered websites such as the ICTRP (International Clinical Trial Registration Platform) and clinicaltrials.gov (https://clinicaltrials.gov/) for case-control studies on PCOS and visfatin levels, assessed the quality of the included articles with the Newcastle-Ottawa Scale (NOS scale), and combined the comparison of serum visfatin levels between patients with PCOS and healthy individuals from high-quality studies. Results: 20 research papers were included in the quantitative analysis of this study. The combined analysis showed that obese patients with PCOS had statistically significantly higher visfatin levels than healthy people [MD (mean difference) = 12.94, 95% CI (confidence interval) (6.52–19.37), Z = 3.95, p < 0.0001]. Visfatin levels were higher in non-obese patients with PCOS than in healthy people and are statistically significant [MD = 14.98, 95% CI (5.80–24.16), Z = 3.20, p = 0.001]. Heterogeneity in the combined analysis was not related to study location, the publication year of the literature, source of serum samples, but was influenced by the quality of the literature. After excluding the most influential papers, the combined analysis was conducted again, and the conclusion was consistent with that before the exclusion. The results of Egger’s test showed no significant publication bias. Conclusions: High serum visfatin levels are a natural feature of PCOS and are not associated with obesity; Serum visfatin levels may be a potential marker for the diagnosis of PCOS, but their relationship with PCOS and insulin resistance remains worthy of in-depth investigation.Keywords
This publication has 35 references indexed in Scilit:
- Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesityClinica Chimica Acta, 2020
- Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control StudyJournal of Pediatric and Adolescent Gynecology, 2015
- Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?European Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic reviewDiabetes/Metabolism Research and Reviews, 2011
- Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulationFertility and Sterility, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOSReproductive BioMedicine Online, 2010
- Effect of metformin on serum visfatin levels in patients with polycystic ovary syndromeFertility and Sterility, 2008
- Plasma visfatin levels in normal weight women with polycystic ovary syndromeEuropean Journal of Internal Medicine, 2008
- Increased plasma visfatin concentrations in women with polycystic ovary syndromeFertility and Sterility, 2007